Literature DB >> 8613427

Genetic and epigenetic resistance of SL/Ni mice to lymphomas.

H Shisa1, Y Yamada, A Kawarai, N Terada, M Kawai, H Matsushiro, H Hiai.   

Abstract

The murine spontaneous B lymphoma is etiologically related to the expression of endogenous ecotropic murine leukemia virus (ETV). Although both SL/Kh and SL/Ni mouse strains show a high level of expression of ETV from early in life, the former is a pre-B lymphoma-prone strain and the latter is rather lymphoma-resistant. In order to identify the host background difference related to the lymphomagenesis, we performed a genetic cross study between these two strains. In the reciprocal F1 generation, the length of the lymphoma latent period was slightly but significantly longer in (SL/Ni xSL/Kh)F1 than in (SL/KhxSL/Ni)F1(P < 0.05). The incidence of overall lymphomas and that of acute pre-B lymphomas was lower in (SL/NixSL/Kh)F1 than in (SL/KhxSL/Ni)F1, although the difference was not statistically significant. These observations indicate that an epigenetic maternal resistance mechanism of SL/Ni mice plays a role in the lymphoma resistance. Furthermore, in the backcross combinations without maternal influence of SL/Ni, we observed a genetic mechanism of lymphoma resistance: an SL/Ni-derived recessive lymphoma-resistance gene mapped in the proximal segment of Chr. 4. We named this gene nir-1 (SL/Ni-lymphoma resistance-1). Thus, we have demonstrated epigenetic and genetic mechanisms of lymphoma resistance of the SL/Ni mouse with the high expression of endogenous ETV.

Entities:  

Mesh:

Year:  1996        PMID: 8613427      PMCID: PMC5921086          DOI: 10.1111/j.1349-7006.1996.tb00214.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


ecotropic raurine leukemia virus polymerase chain reaction maternal resistance factor major histocompatibility complex
  11 in total

1.  The origin of SL family mice.

Authors:  P Abujiang; Y Yamada; O Haller; H Kobayashi; T Kamoto; L M Lu; M Ogawa; A Ishimoto; H Katoh; K Kanehira; S Ikegami; M Fukumoto; H Hiai
Journal:  Lab Anim Sci       Date:  1996-08

2.  Epigenetic control of endogenous ecotropic virus expression in SL/Ni mice.

Authors:  H Hiai; Y O Buma; H Ikeda; K Moriwaki; Y Nishizuka
Journal:  J Natl Cancer Inst       Date:  1987-10       Impact factor: 13.506

3.  SL/KH strain of mice: a model of spontaneous pre-B-lymphomas.

Authors:  M O Shimada; Y Yamada; Y Nakakuki; K Okamoto; M Fukumoto; T Honjo; H Hiai
Journal:  Leuk Res       Date:  1993-07       Impact factor: 3.156

4.  p16 gene in uncultured tumours.

Authors:  C H Spruck; M Gonzalez-Zulueta; A Shibata; A R Simoneau; M F Lin; F Gonzales; Y C Tsai; P A Jones
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

5.  Genetic and epigenetic factors that influence the occurrence of spontaneous lymphoid tumors in crosses of mice of high- and low-incidence strains.

Authors:  M L Duran-Reynals; A S Kadish; F Lilly
Journal:  Int J Cancer       Date:  1986-01-15       Impact factor: 7.396

6.  Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice.

Authors:  M Okumoto; R Nishikawa; S Imai; J Hilgers
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

7.  Genetic predisposition to pre-B lymphomas in SL/Kh strain mice.

Authors:  Y Yamada; H Matsushiro; M S Ogawa; K Okamoto; Y Nakakuki; S Toyokuni; M Fukumoto; H Hiai
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

9.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Authors:  M Serrano; G J Hannon; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

10.  T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models.

Authors:  Y Yamada; H Shisa; H Matsushiro; T Kamoto; Y Kobayashi; A Kawarai; H Hiai
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.